In these patients, tumor removal in the first operation led to an obvious decrease in the proportions of IL-8+ naïve T cells 3 months after surgery; however, the proportions of IL-8+ naïve T cells increased again with tumor recurrence (Fig. 4, Supplementary Fig. 8). This evidence concerns the gene CXCL8 and neoplasm.